Labat Africa Ltd (LAB) - Cash Flow Conversion Efficiency

Latest as of May 2024: -0.077x

Based on the latest financial reports, Labat Africa Ltd (LAB) has a cash flow conversion efficiency ratio of -0.077x as of May 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ZAC1.50 Million ≈ $795.05 USD) by net assets (ZAC-19.45 Million ≈ $-10.34K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Labat Africa Ltd (LAB) balance sheet quality index to measure how much of total assets are equity-financed.

Labat Africa Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Labat Africa Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check LAB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Labat Africa Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Labat Africa Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
NASDAQ:CUPR
-0.738x
Falmaco Nonwoven Industri PT Tbk
JK:FLMC
-0.007x
DSJ Keep Learning Limited
NSE:KEEPLEARN
0.014x
Ostrom Climate Solutions Inc
V:COO
-0.097x
Marvel Discovery Corp
V:MARV
0.000x
Yunji Inc
NASDAQ:YJ
N/A
Harris Technology Group Ltd
AU:HT8
-0.192x
Kane Biotech Inc
V:KNE
0.912x

Annual Cash Flow Conversion Efficiency for Labat Africa Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Labat Africa Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Labat Africa Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-08-31 ZAC247.41 Million
≈ $131.48K
ZAC-15.13 Million
≈ $-8.04K
-0.061x +60.24%
2024-08-31 ZAC-19.45 Million
≈ $-10.34K
ZAC2.99 Million
≈ $1.59K
-0.154x +71.26%
2023-08-31 ZAC9.79 Million
≈ $5.20K
ZAC-5.24 Million
≈ $-2.78K
-0.535x -186.02%
2022-08-31 ZAC86.45 Million
≈ $45.94K
ZAC-16.17 Million
≈ $-8.60K
-0.187x -262.93%
2021-08-31 ZAC101.31 Million
≈ $53.84K
ZAC-5.22 Million
≈ $-2.78K
-0.052x -123.80%
2020-08-31 ZAC75.96 Million
≈ $40.37K
ZAC16.45 Million
≈ $8.74K
0.217x +130.60%
2019-08-31 ZAC-34.43 Million
≈ $-18.30K
ZAC24.37 Million
≈ $12.95K
-0.708x -1129.37%
2018-08-31 ZAC24.83 Million
≈ $13.20K
ZAC-1.43 Million
≈ $-759.70
-0.058x -136.10%
2017-08-31 ZAC12.25 Million
≈ $6.51K
ZAC1.95 Million
≈ $1.04K
0.159x +127.85%
2016-08-31 ZAC6.63 Million
≈ $3.52K
ZAC-3.79 Million
≈ $-2.02K
-0.573x -122.47%
2015-08-31 ZAC-2.11 Million
≈ $-1.12K
ZAC-5.38 Million
≈ $-2.86K
2.548x -94.62%
2014-08-31 ZAC449.83K
≈ $239.06
ZAC21.32 Million
≈ $11.33K
47.405x +24498.20%
2013-08-31 ZAC-8.58 Million
≈ $-4.56K
ZAC-1.65 Million
≈ $-878.83
0.193x +107.98%
2012-08-31 ZAC1.38 Million
≈ $732.34
ZAC-3.33 Million
≈ $-1.77K
-2.416x -151.87%
2011-08-31 ZAC2.18 Million
≈ $1.16K
ZAC-2.09 Million
≈ $-1.11K
-0.959x -530.93%
2010-08-31 ZAC-25.09 Million
≈ $-13.34K
ZAC-5.58 Million
≈ $-2.97K
0.223x -19.27%
2009-08-31 ZAC-36.57 Million
≈ $-19.43K
ZAC-10.08 Million
≈ $-5.36K
0.276x +164.19%
2006-08-31 ZAC37.62 Million
≈ $19.99K
ZAC-16.16 Million
≈ $-8.59K
-0.429x -2129.95%
2005-08-31 ZAC65.70 Million
≈ $34.91K
ZAC1.39 Million
≈ $738.71
0.021x -83.52%
2004-08-31 ZAC78.46 Million
≈ $41.70K
ZAC10.07 Million
≈ $5.35K
0.128x +458.66%
2003-08-31 ZAC143.72 Million
≈ $76.38K
ZAC3.30 Million
≈ $1.75K
0.023x -47.30%
2002-08-31 ZAC155.95 Million
≈ $82.88K
ZAC6.80 Million
≈ $3.61K
0.044x --

About Labat Africa Ltd

JSE:LAB South Africa Drug Manufacturers - Specialty & Generic
Market Cap
$3.29 Million
ZAC6.20 Billion ZAC
Market Cap Rank
#29289 Global
#213 in South Africa
Share Price
ZAC3.00
Change (1 day)
+50.00%
52-Week Range
ZAC2.00 - ZAC9.00
All Time High
ZAC155.00
About

Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis, as … Read more